<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns="http://formex.publications.europa.eu/ted/schema/export/R2.0.9.S01.E01" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" VERSION="R2.0.9.S01.E01" xsi:schemaLocation="http://formex.publications.europa.eu/ted/schema/export/R2.0.9.S01.E01 TED_EXPORT.xsd" DOC_ID="111567-2017" EDITION="2017060">
<TECHNICAL_SECTION>
<RECEPTION_ID>17-116782-001</RECEPTION_ID>
<DELETION_DATE>20180323</DELETION_DATE>
<FORM_LG_LIST>EN </FORM_LG_LIST>
<COMMENTS>From Convertor</COMMENTS>
</TECHNICAL_SECTION>
<LINKS_SECTION>
<XML_SCHEMA_DEFINITION_LINK xlink:title="TED WEBSITE" xlink:href="http://ted.europa.eu" xlink:type="simple"/>
<OFFICIAL_FORMS_LINK xlink:href="http://ted.europa.eu" xlink:type="simple"/>
<FORMS_LABELS_LINK xlink:href="http://ted.europa.eu" xlink:type="simple"/>
<ORIGINAL_CPV_LINK xlink:href="http://ted.europa.eu" xlink:type="simple"/>
<ORIGINAL_NUTS_LINK xlink:href="http://ted.europa.eu" xlink:type="simple"/>
</LINKS_SECTION>
<CODED_DATA_SECTION>
<REF_OJS>
<COLL_OJ>S</COLL_OJ>
<NO_OJ>60</NO_OJ>
<DATE_PUB>20170325</DATE_PUB>
</REF_OJS>
<NOTICE_DATA>
<NO_DOC_OJS>2017/S 060-111567</NO_DOC_OJS>
<URI_LIST>
<URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:111567-2017:TEXT:EN:HTML</URI_DOC>
</URI_LIST>
<LG_ORIG>EN</LG_ORIG>
<ISO_COUNTRY VALUE="UK"/>
<IA_URL_GENERAL>www.supc.ac.uk</IA_URL_GENERAL>
<ORIGINAL_CPV CODE="33651500">Immune sera and immunoglobulins</ORIGINAL_CPV>
<ORIGINAL_CPV CODE="33651520">Immunoglobulins</ORIGINAL_CPV>
<ORIGINAL_CPV CODE="33141510">Blood products</ORIGINAL_CPV>
<ORIGINAL_NUTS CODE="UK">UNITED KINGDOM</ORIGINAL_NUTS>
<CA_CE_NUTS CODE="UK">UNITED KINGDOM</CA_CE_NUTS>
<VALUES>
<VALUE TYPE="ESTIMATED_TOTAL" CURRENCY="GBP">240000000.00</VALUE>
</VALUES>
</NOTICE_DATA>
<CODIF_DATA>
<DS_DATE_DISPATCH>20170323</DS_DATE_DISPATCH>
<AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE>
<TD_DOCUMENT_TYPE CODE="0">Prior information notice without call for competition</TD_DOCUMENT_TYPE>
<NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
<PR_PROC CODE="9">Not applicable</PR_PROC>
<RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
<TY_TYPE_BID CODE="2">Submission for one lot only</TY_TYPE_BID>
<AC_AWARD_CRIT CODE="Z">Not specified</AC_AWARD_CRIT>
<MA_MAIN_ACTIVITIES CODE="L">Education</MA_MAIN_ACTIVITIES>
<HEADING>01B01</HEADING>
<INITIATOR>01</INITIATOR>
<DIRECTIVE VALUE="2014/24/EU"/>
</CODIF_DATA>
</CODED_DATA_SECTION>
<TRANSLATION_SECTION>
<ML_TITLES>
<ML_TI_DOC LG="BG">
<TI_CY>Обединено кралство</TI_CY>
<TI_TOWN>Рединг</TI_TOWN>
<TI_TEXT>
<P>Имуносеруми и имуноглобулини</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="CS">
<TI_CY>Spojené království/Velká Británie</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Imunitní séra a imunoglobuliny</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="DA">
<TI_CY>Forenede Kongerige, Det</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Immunsera og immunoglobuliner</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="DE">
<TI_CY>das Vereinigte Königreich</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Immunsera und Immunglobuline</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="EL">
<TI_CY>Ηνωμένο Βασίλειο</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Οροί κατά των δηλητηριάσεων και ανοσοσφαιρίνες</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="EN">
<TI_CY>United Kingdom</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Immune sera and immunoglobulins</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="ES">
<TI_CY>Reino Unido</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Inmunosueros e inmunoglobulinas</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="ET">
<TI_CY>Suurbritannia / Ühendkuningriik</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Immuunseerumid ja immuunglobuliinid</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="FI">
<TI_CY>Yhdistynyt kuningaskunta</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Immunoseerumit ja immonoglobuliinit</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="FR">
<TI_CY>Royaume-Uni</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Immun-sérums et immunoglobulines</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="GA">
<TI_CY>Ríocht Aontaithe, an</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Immune sera and immunoglobulins</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="HR">
<TI_CY>Ujedinjena Kraljevina</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Imunski serumi i imunoglobulini</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="HU">
<TI_CY>Egyesült Királyság</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Immunszérumok és immunglobulinok</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="IT">
<TI_CY>Regno Unito</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Immunosieri e immunoglobuline</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="LT">
<TI_CY>Jungtinė Karalystė, Didžioji Britanija</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Imuniniai serumai ir imunoglobulinai</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="LV">
<TI_CY>Apvienotā Karaliste</TI_CY>
<TI_TOWN>Redinga</TI_TOWN>
<TI_TEXT>
<P>Imūnserumi un imūnglobulīni</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="MT">
<TI_CY>Ir-Renju Unit</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Sera immuloġika u immunoglobulini</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="NL">
<TI_CY>Verenigd Koninkrijk</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Immuunsera en immunoglobulinen</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="PL">
<TI_CY>Zjednoczone Królestwo</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Surowice odpornościowe oraz immunoglobuliny</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="PT">
<TI_CY>Reino Unido</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Soros imunizantes e imunoglobulinas</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="RO">
<TI_CY>Regatul Unit</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Imunoseruri şi imunoglobuline</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="SK">
<TI_CY>Spojené kráľovstvo</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Imunitné očkovacie látky a imunoglobulíny</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="SL">
<TI_CY>Združeno kraljestvo</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Imunski serumi in imunoglobulini</P>
</TI_TEXT>
</ML_TI_DOC>
<ML_TI_DOC LG="SV">
<TI_CY>Förenade kungariket</TI_CY>
<TI_TOWN>Reading</TI_TOWN>
<TI_TEXT>
<P>Immunserum och immunglobuliner</P>
</TI_TEXT>
</ML_TI_DOC>
</ML_TITLES>
<ML_AA_NAMES>
<AA_NAME LG="EN">Southern Universities Purchasing Consortium (SUPC)</AA_NAME>
</ML_AA_NAMES>
</TRANSLATION_SECTION>
<FORM_SECTION>
<F01_2014 CATEGORY="ORIGINAL" FORM="F01" LG="EN">
<NOTICE TYPE="PRI_REDUCING_TIME_LIMITS"/>
<CONTRACTING_BODY>
<ADDRESS_CONTRACTING_BODY>
<OFFICIALNAME>Southern Universities Purchasing Consortium (SUPC)</OFFICIALNAME>
<ADDRESS>Science and Technology Centre, Earley Gate, University of Reading</ADDRESS>
<TOWN>Reading</TOWN>
<POSTAL_CODE>RG6 6BZ</POSTAL_CODE>
<COUNTRY VALUE="UK"/>
<PHONE>+44 1189357081</PHONE>
<E_MAIL>e.rigopoulou@reading.ac.uk</E_MAIL>
<NUTS CODE="UK"/>
<URL_GENERAL>www.supc.ac.uk</URL_GENERAL>
<URL_BUYER>https://in-tendhost.co.uk/supc/</URL_BUYER>
</ADDRESS_CONTRACTING_BODY>
<CENTRAL_PURCHASING/>
<ADDRESS_FURTHER_INFO_IDEM/>
<URL_PARTICIPATION>https://in-tendhost.co.uk/supc/</URL_PARTICIPATION>
<CA_TYPE VALUE="BODY_PUBLIC"/>
<CA_ACTIVITY VALUE="EDUCATION"/>
</CONTRACTING_BODY>
<OBJECT_CONTRACT ITEM="1">
<TITLE>
<P>IRLA Antibodies and Sera (and other related matrices) for Research Purpose.</P>
</TITLE>
<REFERENCE_NUMBER>2016/06</REFERENCE_NUMBER>
<CPV_MAIN>
<CPV_CODE CODE="33651500"/>
</CPV_MAIN>
<TYPE_CONTRACT CTYPE="SUPPLIES"/>
<SHORT_DESCR>
<P>The supply and distribution of antibodies and sera nationally for research purpose, to all institutions that are members of APUC, HEPCW, NEUPC, NWUPC, LUPC, SUPC.</P>
</SHORT_DESCR>
<VAL_ESTIMATED_TOTAL CURRENCY="GBP">240000000.00</VAL_ESTIMATED_TOTAL>
<LOT_DIVISION>
<LOT_ONE_ONLY/>
</LOT_DIVISION>
<OBJECT_DESCR ITEM="1">
<TITLE>
<P>Antibodies</P>
</TITLE>
<LOT_NO>1</LOT_NO>
<CPV_ADDITIONAL>
<CPV_CODE CODE="33651520"/>
</CPV_ADDITIONAL>
<NUTS CODE="UK"/>
<MAIN_SITE>
<P>Various locations across the UK.</P>
</MAIN_SITE>
<SHORT_DESCR>
<P>The supply and distribution of Antibodies for research purposes only.</P>
</SHORT_DESCR>
<VAL_OBJECT CURRENCY="GBP">160000000.00</VAL_OBJECT>
<DURATION TYPE="MONTH">48</DURATION>
<OPTIONS/>
<OPTIONS_DESCR>
<P>The Framework Agreement will be awarded initially for 2 years, SUPC may choose to extend this twice up to a further 24 months. The total duration of the Framework will not exceed 4 years.</P>
</OPTIONS_DESCR>
<EU_PROGR_RELATED>EU funds may be used in procuring products used in a variety of projects by any member of APUC, HEPCW, LUPC, NWUPC, NEUPC, SUPC.</EU_PROGR_RELATED>
</OBJECT_DESCR>
<OBJECT_DESCR ITEM="2">
<TITLE>
<P>Sera (and other related matrices)</P>
</TITLE>
<LOT_NO>2</LOT_NO>
<CPV_ADDITIONAL>
<CPV_CODE CODE="33651500"/>
</CPV_ADDITIONAL>
<CPV_ADDITIONAL>
<CPV_CODE CODE="33141510"/>
</CPV_ADDITIONAL>
<NUTS CODE="UK"/>
<MAIN_SITE>
<P>Various locations across the UK.</P>
</MAIN_SITE>
<SHORT_DESCR>
<P>The supply of sera (and other related matrices) for research purpose.</P>
</SHORT_DESCR>
<VAL_OBJECT CURRENCY="GBP">80000000.00</VAL_OBJECT>
<DURATION TYPE="MONTH">48</DURATION>
<OPTIONS/>
<OPTIONS_DESCR>
<P>The Framework Agreement will be awarded for 2 years initially and SUPC may choose to extend twice up to 24 months. In total the duration of the Framework Agreement will not exceed 48 months.</P>
</OPTIONS_DESCR>
<EU_PROGR_RELATED>EU funds may be used in procuring products used in a variety of projects by any member of APUC, HEPCW, LUPC, NWUPC, NEUPC, SUPC.</EU_PROGR_RELATED>
</OBJECT_DESCR>
<DATE_PUBLICATION_NOTICE>2017-05-05</DATE_PUBLICATION_NOTICE>
</OBJECT_CONTRACT>
<LEFTI>
<ECONOMIC_CRITERIA_DOC/>
<TECHNICAL_CRITERIA_DOC/>
</LEFTI>
<PROCEDURE>
<FRAMEWORK>
<SEVERAL_OPERATORS/>
<NB_PARTICIPANTS>70</NB_PARTICIPANTS>
</FRAMEWORK>
<EAUCTION_USED/>
<INFO_ADD_EAUCTION>
<P>An e-auction will not be used as part of the tender, however it may be used by Member Institutions when they call-off.</P>
</INFO_ADD_EAUCTION>
<CONTRACT_COVERED_GPA/>
<DATE_AWARD_SCHEDULED>2017-08-28</DATE_AWARD_SCHEDULED>
</PROCEDURE>
<COMPLEMENTARY_INFO>
<EORDERING/>
<EINVOICING/>
<EPAYMENT/>
<INFO_ADD>
<P>Note: To register your interest in this notice and obtain any additional information please visit the myTenders Web Site at http://www.myTenders.org/Search/Search_Switch.aspx?ID=195531.</P>
<P>(MT Ref:195531).</P>
</INFO_ADD>
<ADDRESS_REVIEW_BODY>
<OFFICIALNAME>Southern Universities Purchasing Consortium (SUPC)</OFFICIALNAME>
<ADDRESS>Science and Technology Centre, Earley Gate, University of Reading</ADDRESS>
<TOWN>Reading</TOWN>
<POSTAL_CODE>RG6 6BZ</POSTAL_CODE>
<COUNTRY VALUE="UK"/>
<PHONE>+44 1189357081</PHONE>
<URL>www.supc.ac.uk</URL>
</ADDRESS_REVIEW_BODY>
<DATE_DISPATCH_NOTICE>2017-03-23</DATE_DISPATCH_NOTICE>
</COMPLEMENTARY_INFO>
</F01_2014>
</FORM_SECTION>
</TED_EXPORT>
